Anatomical Characteristics of Patent Ductus Arteriosus and Choice of Transcatheter Occluder Devices

Authors

  • Saima Rafique Department of Paeds Cardiology, Armed Forces Institute of Cardiology/National Institute of Heart Diseases/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
  • Sana Imtiaz Department of Paeds Cardiology, Armed Forces Institute of Cardiology/National Institute of Heart Diseases/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
  • Khurram Akhtar Department of Paeds Cardiology, Armed Forces Institute of Cardiology/National Institute of Heart Diseases/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
  • Amjad Mehmood Department of Paeds Cardiology, Armed Forces Institute of Cardiology/National Institute of Heart Diseases/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
  • Andaleeb Ara Department of Paeds Cardiology, Armed Forces Institute of Cardiology/National Institute of Heart Diseases/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
  • Abdul Wahab Department of Paeds Cardiology, Armed Forces Institute of Cardiology/National Institute of Heart Diseases/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
  • Abubakar Sadiq Department of Paeds Cardiology, Armed Forces Institute of Cardiology/National Institute of Heart Diseases/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
  • Javeria Kamran Department of Research & Development, Armed Forces Institute of Cardiology/National Institute of Heart Diseases/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan

DOI:

https://doi.org/10.51253/pafmj.v74iSUPPL-1.11562

Keywords:

Device occlusion, Embolization, Krichenko classification, Patent Ductus Arteriosus, Trans catheter

Abstract

Objective: To determine the anatomical characteristics of Patent Ductus Arteriosus, choice of transcatheter occluder device and outcomes of Patent Ductus Arteriosus device closure.

Study Design: Analytical Cross-sectional study.

Place and Duration of Study: Paediatric Cardiology Department, Armed Forces Institute of Cardiology/National Institute of Heart Diseases, Rawalpindi Pakistan, from Jan-July 2023.

Methodology: A total of n=90 patients regardless of age and gender presenting with Patent Ductus Arteriosus, who underwent device closure were enrolled in this study by universal sampling. Data of the patients was collected on pre-designed proforma. Pearson's Chi-square test was applied to find association of morphological type of ductus and the weight of patient with the type of device used. p-value < 0.05 was considered as statistically significant.

Results: Among n=90 patients, 56(62.2%) were females and 34(37.8%) were males with median age of 1(IQR=0.6-4.25) years who underwent transcatheter device closure. The most common ductus types treated were Krichenko type-A 70(76.7%). Devices used were VSD device 15(16.7%), ADO-II 6(6.7%) and ADO-I device (conventional duct occluder) 69(76.7%). Median fluoroscopy time was 8.40(7.2-12.07) minutes. Statistically significant relationships were observed between Krichenko classification of Patent Ductus Arteriosus, weight of patient and type of device used to occlude the Patent Ductus Arteriosus (p<0.001). Success rate was 88(97.7%). Complications occurred in only 2(2.2%) patients in the form of device embolization. In 1(1.1%) patient, embolized device was retrieved while, the other patient was referred for surgical retrieval.

Conclusion: Transcatheter Patent Ductus Arteriosus device closure is a standard and safe procedure for closure of ductus with vari..

Downloads

Download data is not yet available.

References

Hwang HJ, Yoon KL, Sohn IS. Transient severe left ventricular dysfunction following percutaneous patent ductus arteriosus closure in an adult with bicuspid aortic valve: A case report. Exp Ther Med. 2016; 11(3): 969-72.

https//doi.org: 10.3892/etm.2015.3014

Abdel-Bary M, Abdel-Baseer KA, Abdel-Latif AF, Abdel-Naser MA, Nafie M, Eisa KM. Left ventricular dysfunction postsurgical patent ductus arteriosus ligation in children: predictor factors analysis. J Cardiothorac Surg. 2019; 14(1): 168.

https//doi.org: 10.1186/s13019-019-1025-8

Dice JE, Bhatia J. Patent ductus arteriosus: an overview. J Pediatr Pharmacol Ther. 2007; 12(3): 138-46.

https//doi.org: 10.5863/1551-6776-12.3.138

Agha HM, Hamza HS, Kotby A, Ganzoury MEL, Soliman N. Predictors of transient left ventricular dysfunction following transcatheter patent ductus arteriosus closure in pediatric age. J Saudi Heart Assoc. 2017; 29(4): 244-51.

https//doi.org: 10.1016/j.jsha.2016.12.001

Hou M, Qian W, Wang B, Zhou W, Zhang J, Ding Y, et al. Echocardiographic Prediction of Left Ventricular Dysfunction After Transcatheter Patent Ductus Arteriosus Closure in Children. Front Pediatr. 2019; 7: 409.

https//doi.org: 10.3389/fped.2019.00409

Khan AM, Ullah Z, Ilyas S, Wazir HD, Rehman Y, Hussain I, et al. The Outcome of Transcatheter Closure of Patent Ductus Arteriosus: A Single-Center Experience. Cureus. 2022; 14(1): e21577.

https//doi.org: 10.7759/cureus.21577

Ezzeldin D, Wahba S, El Sayed M, Roushdy A. Immediate- and Short-Term Effect of Percutaneous Patent Ductus Arteriosus Closure on Left Ventricular Function: A Speckle Tracking Echocardiographic Study. Journal of The Indian Academy of Echocardiography & Cardiovascular Imaging. 2020; 4(2).

https//doi.org: 10.4103/jiae.jiae_35_19

Nour A, Abdelrazik Y, Huessin S, Kamel H. Safety and efficacy of percutaneous patent ductus arteriosus closure: a multicenter Egyptian experience. The Egyptian Heart Journal. 2022; 74(1): 1-7. https//doi.org: 10.1016/j.ehj.2021.07.009

Sultan M, Ullah M, Sadiq N, Akhtar K, Akbar H. Transcatheter device closure of patent ductus arteriosus. J Coll Physicians Surg Pak. 2014; 24(10): 710-3. https//doi.org: 10.2014/JCPSP.710710

El-Saiedi SA, Zoair AM, Agha HM, El-Shedoudy S, Fattouh AM, Abu-Farag IM, et al. Tubular PDA versus other PDA types: Challenging device choice for transcatheter closure. Progress in pediatric Cardiology. 2022; 64: 101434.

https//doi.org: 10.1016/j.ppedcard.2021.101434

Gruenstein DH, Ebeid M, Radtke W, Moore P, Holzer R, Justino H. Transcatheter closure of patent ductus arteriosus using the AMPLATZER duct occluder II (ADO II). Catheter Cardiovasc Interv. 2017; 89(6): 1118-28. https//doi.org: 10.1002/ccd.26856

Mehmmood K. To study the residual leak within 24 hours after Transcatheter closure of PDA with different types of duct occluder Asia Pac J Paediatr Child Health. 2021; 4.

https//doi.org: 10.21203/rs.3.rs-922529/v1

Zulqarnain A, Younas M, Waqar T, Beg A, Asma T, Baig MAR. Comparison of effectiveness and cost of patent ductus arteriosus device occlusion versus surgical ligation of patent ductus arteriosus. Pakistan Journal of Medical Sciences. 2016; 32(4): 974.

https//doi.org: 10.12669/pjms.324.10173

Yıldız Sr K, Kir M, Prencuva P, Genc HZ, Celiktepe V, Bozyer HE, et al. Transcatheter Patent Ductus Arteriosus Closure in Children With Different Devices and Long-Term Results. Cureus. 2023; 15(10). https//doi.org : 10.7759/cureus.11350

Baspinar O, Irdem A, Sivasli E, Sahin DA, Kilinc M. Comparison of the efficacy of different-sized Amplatzer duct occluders (I, II, and II AS) in children weighing less than 10 kg. Pediatric cardiology. 2013; 34: 88-94. https//doi.org: 10.1007/s00246-012-0411-7

Maksymenko AV, Kuzmenko YL, Dovhaliuk AA, Motrechko OO, Herrmann FE, Haas NA, et al. Percutaneous closure of patent ductus arteriosus with the Nit-Occlud® patent ductus arteriosus device in 268 consecutive cases. Annals of Pediatric Cardiology. 2019; 12(3): 206.

https//doi.org: 10.4103/apc.APC_144_18

El‐Said HG, Bratincsak A, Foerster SR, Murphy JJ, Vincent J, Holzer R, et al. Safety of percutaneous patent ductus arteriosus closure: an unselected multicenter population experience. Journal of the American Heart Association. 2013; 2(6): e000424 https//doi.org 10.1161/JAHA.113.000424

Atik SU, Saltık İL. Transcatheter coil occlusion of patent ductus arteriosus and follow-up results. Turk Kardiyoloji Dernegi arsivi: Turk Kardiyoloji Derneginin yayin organidir. 2019; 47(4): 265-72. https//doi.org 10.5543/tkda.2018.12756

Backes CH, Rivera BK, Bridge JA, Armstrong AK, Boe BA, Berman DP, et al. Percutaneous patent ductus arteriosus (PDA) closure during infancy: a meta-analysis. Pediatrics. 2017; 139(2). https//doi.org 10.1542/peds.2016-3338

Bruckheimer E, Steiner K, Barak-Corren Y, Slanovic L, Levinzon M, Lowenthal A, et al. The Amplatzer duct occluder (ADOII) and Piccolo devices for patent ductus arteriosus closure: a large single institution series. Frontiers in Cardiovascular Medicine. 2023; 10: 1158227. https//doi 10.3389/fcvm.2023.1158227

Downloads

Published

30-05-2024

Issue

Section

Original Articles

How to Cite

1.
Rafique S, Imtiaz S, Akhtar K, Mehmood A, Ara A, Wahab A, et al. Anatomical Characteristics of Patent Ductus Arteriosus and Choice of Transcatheter Occluder Devices. Pak Armed Forces Med J [Internet]. 2024 May 30 [cited 2024 Jun. 16];74(SUPPL-1):S62-S67. Available from: https://pafmj.org/PAFMJ/article/view/11562